FGFR1/2/3

Notes

original target text: FGFR1/2/3 inhibitor

Fibroblast growth factor receptors 1, 2, and 3 (FGFR1/2/3) are cell-surface receptor tyrosine kinases that transmit signals from fibroblast growth factors, a family of extracellular proteins involved in cell growth, tissue repair, and blood vessel formation. When a growth factor binds the receptor's outer portion, the receptor pairs with another copy of itself and activates internal enzymatic machinery that switches on downstream growth and survival pathways inside the cell. In a subset of cancers, genetic alterations such as gene fusions, amplifications, or activating mutations cause FGFR1, 2, or 3 to signal continuously without needing the normal growth factor trigger, driving uncontrolled cell division. Small-molecule inhibitors that block the kinase activity shared across these three closely related receptors can shut down this aberrant signaling, offering a targeted approach in tumors where FGFR alterations are identified as a driving event. Because FGFR1, 2, and 3 share substantial structural similarity, a single inhibitor can often act on all three, which is useful since different tumor types are associated with alterations in different family members. This mechanism is relevant across several solid tumors where FGFR pathway activation has been identified as a contributor to disease, and it belongs to the broader category of precision oncology approaches that target specific molecular drivers rather than all rapidly dividing cells indiscriminately.